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AbstrAct
Objectives: Nuclear factor kappa B (NF-кB) is a member of the transcription factor family, and it 
plays a key role in coordinating the expression of genes in many chronic inflammatory diseases. This 
study investigated the cytoplasmic and nuclear activation of (NF-кB) and the cytoplasmic expression 
of inhibitor kappa B (IкB) in gingival tissues of subjects who had chronic periodontitis. 
Methods: Thirty-five patients were included in this study; 17 patients had chronic periodontitis, 
and 18 were healthy. Gingival tissues were obtained from each individual and then stained immu-
nohistochemically. The obtained sections were examined under a stereomicroscope, and the nu-
merical density values of the stained cells were computed using the stereologic method. A one-way 
analysis of variance (ANOVA) and a multiple range least significant difference (LSD) were used for 
intergroup comparisons (P=0.05).
Results: According to the immunohistochemical analysis of the cytoplasmic positive cells stained 
with IкB, statistically significant differences were found between the case and control groups. When 
comparing the cytoplasmic and nuclear positive immunoreactivity of p50 and p65, statistically sig-
nificant differences were found between the diseased and control groups. Statistically significant 
correlations were also found between the clinical periodontal scores and the immunohistochemical 
results of the diseased subjects. 
Conclusions: It was shown that NF-кB was highly activated in subjects who had chronic periodon-
titis, compared to healthy controls. The findings of this study can be useful in planning new treat-
ment strategies for periodontal diseases. Further investigations are needed to understand more 
about the signaling mechanisms of inflammatory mediators and their interactions with NF-кB in 
chronic periodontitis. (Eur J Dent 2010;4:454-461)
Key words: Nuclear factor kappa B; Chronic periodontitis; Cytokine.
Taner Arabacia 
Yasin Ciceka  
Varol Canakcia  
Cenk Fatih Canakcia 
Mehmet Ozgoza 
Mevlut Albayrakb 
Osman Nuri Kelesc 
 
Immunohistochemical and Stereologic 
Analysis of NF-κB Activation in 
Chronic Periodontitis
a  Department of Periodontology, Atatürk University 
  Faculty of Dentistry, Erzurum, Turkey.
b  Department of Histology, Atatürk University 
  Faculty of Medicine, Erzurum, Turkey.
c  Department of Pathology, Atatürk University 
  Faculty of Medicine, Erzurum, Turkey.
 
Corresponding author: 
Dr. Taner Arabacı
Atatürk Üniversitesi Diş Hekimliği Fakültesi
Periodontoloji Anabilim Dalı 25240, Erzurum, Turkey.
Fax: +90 442 2360945    
E-mail: t-arabaci@hotmail.comOctober 2010 - Vol.4
455
European Journal of Dentistry
455
Periodontitis is a chronic inflammatory dis-
ease caused by microbial dental plaque. Bacterial 
colonization and subsequent bacterial invasion 
into the gingival sulcus are the primary etiologic 
factors for periodontal diseases.1 In addition to 
pathogenic microorganisms in the biofilm, genetic 
and environmental factors (especially tobacco 
use) contribute to the cause of these diseases.2,3 
Chronic periodontitis is the most common form of 
the periodontal diseases that result in loss of con-
nective tissue attachment and bone support. Ac-
cordingly, chronic periodontitis is a major cause of 
tooth loss in adults.4 The interactions between mi-
croorganisms and host response play a key role in 
the disease’s pathogenesis.5 The immune and in-
flammatory responses to the chronic presence of 
microorganisms result in the destruction of struc-
tural components in the periodontium. Although 
bacteria are necessary for periodontal disease’s 
occurrence, a susceptible host is also needed. The 
host response is essentially protective, but both 
hypo-responsiveness and hyper-responsiveness 
in the immune system can result in enhanced tis-
sue destruction.6 As with other chronic inflamma-
tory diseases, the exact etiology of periodontitis 
is still obscure, and little is known about the mo-
lecular changes and the signaling cascade of the 
host response.7 Consequently, recent studies have 
endeavored to elucidate the role of host response 
in pathogenesis rather than examining the direct 
destruction of the tissues by microorganisms. 
The pathogenesis of chronic inflammatory 
periodontal disease is likely modulated by genetic 
and environmental factors. Transcription factors 
are gene-specific factors that often act as links be-
tween genetic and environmental factors. Nuclear 
factor kappa B (NF-κB) is a transcription factor, 
first identified by Sen and Baltimore,8 that coordi-
nates the expression of a wide variety of genes re-
sponsible for inflammation.9 NF-κB is an important 
family of transcription factors, and it represents 
a group of structurally related and evolutionarily 
conserved dimeric proteins that belong to the Rel 
family.10 Mammals express 5 NF-κB proteins, in-
cluding NF-κB-1 (p50), NF-κB-2 (p52), Rel A (p65), 
Rel-B, and c-Rel.11 These proteins have structur-
ally conserved amino-terminal 300-amino-acid 
regions, which contain the dimerization, nuclear-
localization, and DNA-binding domains.12 
IntroductIon The primary activated form of NF-κB is a het-
erodimer of the p65 subunit associated with either 
the p50 or the p52 subunit.11 In unstimulated cells, 
NF-κB is bound to its inhibitors, called inhibitor 
kappa B (IκB) proteins, and it resides in the cyto-
plasm as an inactive NF-κB/IκB complex.13 NF-
κB can be activated within minutes by a variety of 
stimuli, such as tumor necrosis factor-α (TNFα), 
interleukin-1β (IL-1β), IL-6, reactive oxygen in-
termedies (ROIs), receptor activator NF-κB ligand, 
ultraviolet irradiation, lipolisakkarides (LPS), and 
other bacterial and viral agents.14 Among them, 
the strongest activators of NF-κB are TNFα and 
IL-1β of the proinflammatory cytokines.15 NF-
κB activation is regulated by direct interactions 
with IκB family members, including IκB-α, IκB-β, 
and IκB-ε. IκBs mask the nuclear localization se-
quences of NF-κB and hinder the recognition of 
the NF-κB nuclear localization signal (NLS) by the 
nuclear import machinery, thus retaining NF-κB in 
the cytoplasm. Following the stimulation of cells, 
IκB is first phosporylated by IκB kinases (IKK) and 
then rapidly degraded by proteasomes.16,17 IκB 
degradation results in the translocation of NF-κB 
into the nucleus, where it binds to DNA regulatory 
sites (called κB sites) to activate specific target 
gene expression.18
NF-κB activation by nuclear translocation 
plays a central role in inflammation through its 
ability to induce the transcription of proinflam-
matory genes.17 Cellular events associated with 
NF-κB activation include cell-to-cell adhesion, 
cell recruitment or transmigration of inflamma-
tory cells, and the amplification or spreading of 
primary pathogenic signals.7 NF-κB activation 
is associated with many chronic immune and in-
flammatory diseases such as inflammatory bowel 
disease, asthma, oral lichen planus, pancreatitis, 
AIDS, and arthritis.19, 20 However, several systemic 
conditions that are linked with periodontitis (such 
as atherosclerosis, diabetes mellitus, and smok-
ing) are also associated with NF-κB activation.21, 
22 Stimulators that are identified as crucial NF-кB 
activators (such as LPS, TNFα, IL-1β, and RANKL) 
are found in abundance in the periodontal tissues 
of subjects who have periodontitis. These mol-
ecules are mentioned as important inducers of 
immune and inflammatory responses associated 
with soft tissue destruction and bone resorption 
in the tooth-supporting structures.23,24 In addi-
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tion, the target genes of NF-кB in the inflammatory 
process are believed to facilitate the progression 
of periodontitis. Therefore, the present study com-
pared the nuclear expression of activated NF-кB 
(p50/p65) and IкB in the gingival tissues of the sub-
jects who had chronic periodontitis and the clini-
cally healthy controls. 
MAtErIALs And MEtHods
Population selection
The study population was selected from patients 
who reported to the outpatient division of Atatürk 
University’s Faculty of Dentistry, Department of 
Periodontology, in Erzurum, Turkey, in 2007. The 
case and control groups comprised a total of 35 pa-
tients (17 chronic periodontitis and 18 healthy sub-
jects). The groups excluded patients with any form 
of systemic disease, those who had taken any form 
of medication over the last six months, and smok-
ers. The case group included 9 males and 8 fe-
males (29 to 46 years old; mean 36.7 years) who re-
quired tooth extraction due to poor prognosis. Eight 
males and 10 females (23 to 37 years old; mean 
30.9 years) who required tooth extraction for rea-
sons other than periodontal disease were selected 
for the control group. Periodontal conditions were 
diagnosed by radiographic and detailed periodontal 
examination, which included gingival inflammation 
assessment by bleeding on probing (BOP), probing 
depth (PD), plaque index (PI), calculus index (CI), 
mobility, and clinical attachment loss (CAL).
Collection of the tissues 
The patients in the case and control groups 
were informed about the study so that they could 
give their consent. 1 to 2 mm of gingival tissue was 
taken from the buccal side of the tooth of each sub-
ject before extraction. Next, the biopsies were im-
mediately fixed in 10% neutral buffered formalin 
and sent to the pathology department for immuno-
histochemistry and stereologic examination. 
Immunohistochemistry 
The samples were dehydrated in a graded etha-
nol series and embedded in paraffin wax for immu-
nohistochemical analysis. Sections approximately 
10 μm thick were taken from paraffin blocks to 
positive charged lams and were incubated by 
15-minute segments at 70°C. All the sections were 
deparaffinized in graded xyilol, then hydrated in dif-
ferent absolute (99.8%) alcohol solutions, and then 
rinsed in distilled water. After the antigen retrieval 
procedure, using a 0.01 M citrate buffer, the sec-
tions were rinsed in distilled water and then incu-
bated with 3% H2O2. The sections were rinsed with 
phosphate-buffered saline (PBS/pH = 7.4). Sections 
were incubated overnight at 4°C with the respective 
primary monoclonal antibody,* anti-p50, -p65, and 
IkBα dilutions (1:150, 1:50, and 1:50, respectively). 
Immunohistochemical staining was performed us-
ing the streptavidin-biotin complex (strept-ABC) 
method. All sections were then counterstained with 
hematoxylin.
Stereologic investigation
Stereology is a method that utilizes random, 
systematic sampling to provide unbiased and 
quantitative data. It provides practical techniques 
for extracting quantitative information about a 
three-dimensional material from measurements 
conducted with two-dimensional planar sections of 
the material. In healthy and diseased gingival tis-
sues, the numerical density of cells (according to 
the antibodies’ stains) was evaluated stereologi-
cally. Stereological analyses were performed in a 
stereology workstation consisting of a modified 
light  microscope  (Leica  DM4000  B),  a  motorized 
specimen stage for automatic sampling (BioPre-
cision MAC 5000 controller system), a CCD color 
video camera (Optronics MicroFire), and stereology 
software (Stereo Investigator version 6.0, Micro-
brightfield, Colchester, VT). The unbiased counting 
frame-fractionator combination is a stereological 
method for counting cells in tissue sections.25,26 In 
our study, we used the unbiased counting frame 
and fractionator methods to estimate numerical 
density of cells according to staining with antibod-
ies in the gingiva. Each glass microscope slide was 
sampled using the fractionator principle of the ste-
reology software (Figure 1). Cells were counted us-
ing a 40x Leica Plan Apo objective (NA=1.40), which 
allowed accurate recognition (Figure 1). Each cell 
was counted by the stereology software accord-
ing to the unbiased counting frame (Figure 1). The 
numerical density was estimated according to the 
formula given below:     
Nd = TM/CFA x NSS,
where Nd is numerical density, TM is total mark-
ers, CFA is counting frame area (XY) (μm²), and NSS 
is number of sampling sites.
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Statistical analysis
A one-way analysis of variance (ANOVA) and a 
multiple range least significant difference (LSD) 
were used for intergroup comparisons (P=0.05). 
The coefficient of error (CE) for the numerical 
density estimation was the last calculated value. 
The generally accepted highest limit of CE is 5%.27 
In our study, the coefficient of error for the numer-
ical density was found to be 0.05.
 rEsuLts
The clinical periodontal scores of the patients 
are given in Table 1. The present study evaluated 
the nuclear and cytoplasmic NF-κB activations in 
both epithelial and connective tissue cells of the 
periodontitic and clinically healthy tissues. The 
differences between the stained cells of diseased 
and healthy gingival tissues are shown in Figure 1. 
Figure 1. Immunoreactivity for IκB, p50 and p65 in diseased and control gingival tissues: A; p50 in control, B; p50 in diseased, C; p65 in control, D; p65 in diseased, E; IκB in 
contol, and F; IκB in diseased tissues. 
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Table 2 shows the comparisons of the cytoplasmic 
and nuclear immunoreactivities of p50, p65, and 
IκB in healthy and diseased periodontal tissues. 
According to the immunohistochemical analysis, 
there was a statistically significant increase in 
the numerical density values of the cytoplasmic 
positive stained cells of IκB in the case group, 
compared to the control group (P<.001). Statisti-
cally significant differences were found between 
the diseased and control groups when comparing 
the cytoplasmic and nuclear positive immunore-
activities of p50 (P<.05). Similarly, a statistically 
significant increase was found in the numerical 
density values of the nuclear positive stained cells 
of p65 in the diseased group compared to controls 
(P<.05). Statistically significant correlations were 
also found between the clinical periodontal scores 
and the immunohistochemical results of the dis-
eased subjects (P<.001; Table 3). 
dIscussIon
Chronic periodontitis is one of the most preva-
lent forms of periodontal diseases. An infectious 
disease, chronic periodontitis results in an inflam-
mation within the supporting tissues of the teeth, 
progressive attachment loss, and bone loss. As 
with other chronic inflammatory diseases, chronic 
periodontitis is also related to several inflamma-
tory molecules that act in the immune and inflam-
matory process. However, little is known about the 
molecular-level changes that are associated with 
the host response in chronic periodontitis. Both 
the host and the bacteria in the periodontal bio-
film release proteolytic enzymes that cause tissue 
damage. Several products associated with NF-кB 
activation (especially IL-1, TNFα, and RANKL) are 
found in abundance in the diseased periodontium. 
Studies have concluded that RANKL proteins have 
a constant trigger circle with other NF-кB stimu-
lators such as TNF-α and IL-1β ve IL-6. Addition-
ally, studies have found that RANKL-mediated 
osteoclastogenesis plays a pivotal role in inflam-
matory bone resorption.23 Kawai et al23 showed 
the enhanced concentration of RANKL and IL-1β 
in periodontally diseased tissues. TNFα and IL-1β 
Figure 2. Optic dissector procedure and unbiased counting frame with using stereo 
investigator program. 
Control Case
mm±SD mm±SD
PI 0.31±0.15 2.73±0.38*
GI 0.26±0.08 2.12±0.37*
PD 1.23±0.26 4.21±1.09*
CAL 0.00±0.00 4.38±1.03*
Table 1. The mean clinical periodontal scores of the subjects in case and control 
groups.
*: Statistically significant differences within the groups (P<.001).
MND(n/µ3)±SD
Healthy tissues Diseased tissues P value
IκB
Cytoplasmic immunoreactivity 1.2x10-4 ± 0.7x10-4* 4.4x10-4 ± 2.5x10-4 P<.001
p50
Cytoplasmic immunoreactivity 1.4x10-4 ± 1.0x10-4* 3.6x10-4 ± 2.9x10-4 P<.05
Nuclear immunoreactivity 0.3x10-4 ± 0.2x10-4* 1.0x10-4 ± 0.8x10-4 P<.05
p65
Cytoplasmic immunoreactivity 1.2x10-4 ± 0.9x10-4* 6.4x10-4 ± 3.2x10-4 P<.05
Nuclear immunoreactivity 0.3x10-4 ± 0.2x10-4* 2.7x10-4 ± 1.7x10-4 P<.05
Table 2. Comparison of cytoplasmic and nuclear immunoreactivity of p50, p65 and IκB in healthy and diseased periodontal tissues.  
*: Statistically significant differences within the groups (P<.05).
MND: Mean numerical density of the stained cells
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can stimulate osteoclast differentiation in a syner-
gistic fashion and are known to control their own 
expression. An increase of these proinflammatory 
cytokines in the tissues causes the re-production 
of RANKL, TNFα, and IL-1β from the osteoblasts. 
RANKL proteins released from osteoblasts induce 
their own receptors on the osteoclasts and the 
receptor activator NF-кB (RANK), and they regu-
late RANKL-mediated osteoclastogenesis. On the 
other hand, TNFα and IL-1β activate NF-кB in the 
immature osteoclasts and stimulate the formation 
of a mature osteoclast. Hence, understanding of 
the role of NF-кB activation in chronic inflamma-
tion may form a basis for future strategies in the 
treatment of periodontal diseases.
This study evaluated and compared the ex-
pression transcription factor NF-κB in the gingival 
tissues of both healthy and chronic periodontitis 
patients. According to stereologic examinations, 
a striking increment was found in both the cyto-
plasmic immunoreactivity of IкB (P<.001) and the 
nuclear and cytoplasmic expression NF-кB (p50-
p65) (P<.05) in diseased tissues, compared to con-
trols. Over-expression of NF-κB in periodontally 
diseased tissues explains the molecular signaling 
mechanism in the initiation and progression of the 
disease. Moreover, statistically significant correla-
tions were found between the periodontal scores 
(including probing depth and clinical attachment 
level) and the NF-κB activation in diseased sub-
jects (P<.001). The compatibility between the level 
of clinical periodontal scores and NF-κB and IκB 
expression provides evidence of the effectiveness 
of NF-κB activation in chronic periodontal inflam-
mation. However, several systemic conditions 
linked with periodontitis, including atherosclero-
sis and diabetes mellitus, have also been reported 
to enhance NF-κB activation.21,28 In vitro studies 
have demonstrated NF-кB activation in periodon-
tal tissues and by periodontopathogens, including 
Porphyromonas gingivalis.29 Moreover, smoking 
(a risk factor for periodontitis) has recently been 
recognized as an activator of NF-κB.22 NF-κB is an 
essential factor in controlling both immune and in-
flammatory responses. Remarkably, a large num-
ber of genes appear to be targets for activation by 
NF-κB, such as adhesion molecules (e.g., inter-
cellular adhesion molecule-1 [ICAM-1] and vas-
cular-cell adhesion molecule-1 [VCAM-1]), proin-
flammatory cytokines (e.g., TNFα, IL-1 and IL-6), 
proteinases (matrixmetallo proteinase-1 [MMP-1] 
and MMP-9), and inflammatory enzymes (e.g., in-
ducible nitric oxide sythase [iNOS]), which play piv-
otal roles in the chronic inflammatory process.30 
Chronic inflammation perpetuates and ampli-
fies itself through the numerous autocrine and 
paracrine loops of cytokines, acting on the cells 
within a lesion. The cells within the inflammatory 
lesion are subjected to many extracellular stimuli, 
whereas only a handful of inducible transcription 
factors (including NF-κB) appear to play crucial 
roles in the regulation of inflammatory genes.7 Re-
cently, studies have been directed toward produc-
ing specific NF-кB inhibitors, such as NBD pep-
tide and IкBα superrepressor, in order to alter the 
host response in the immune and inflammatory 
processes.7,31 The pathway can be broken by neu-
tralizing the biological activities of extracellular 
inflammatory mediators or by inhibiting cytokine 
production. Because NF-кB is the most important 
inducer of these circles, inhibition of NF-кB may 
provide an efficacious therapeutic strategy. In the 
present study, statistically significant activations 
of p50 and p65 were found in chronic periodontitis 
groups, compared to controls. However, the cyto-
plasmic activity of NF-κB was observed to be high-
er in the diseased group. A correlation between the 
clinical scores and the NF-κB activation was also 
significant when considering the role of NF-κB in 
the disease progression. 
PI GI PD CAL
IκB-cytoplasmic ns ns 0.809** 0.901**
p50-cytoplasmic ns ns 0.703** 0.844**
p50-nuclear ns ns 0.517* 0.503*
p65-cytoplasmic ns ns 0.898** 0.721**
p65-nuclear ns ns 0.554* 0.541*
Table 3. Correlations between the clinical periodontal scores and immunohistochemical results of the diseased subjects.
*: P<.05; **: P<.001; ns: not significant
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concLusIons
It was shown that NF-кB was highly activated in 
subjects who had chronic periodontitis, compared 
to healthy controls. The findings of this study can 
be useful in planning new treatment strategies for 
periodontal diseases. Further investigations are 
needed to understand more about the signaling 
mechanisms of inflammatory mediators and their 
interactions with NF-кB in chronic periodontitis.
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